Terms: = Head and neck cancer AND HOXD11, ENSG00000128713, 3237
20 results:
1. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract] [Full Text] [Related]
2. hoxd11 upregulates JAM-A and exerts oncogenic properties via NF-κB signaling pathway in esophageal squamous cell carcinoma.
Xiong R; Long Q; Zhang X; Xu J; Liu Y; Xiong L; Yang S; Feng G; Song G; Liu K
Hum Cell; 2023 Jan; 36(1):244-257. PubMed ID: 36214988
[TBL] [Abstract] [Full Text] [Related]
3. Human papillomavirus, tobacco, and poor oral hygiene can act synergetically, modulate the expression of the nuclear factor kappa B signaling pathway for the development and progression of head and neck cancer in the Pakistani population.
Sarwar S; Mulla M; Mulla M; Tanveer R; Sabir M; Sultan A; Malik SA
Chin Med J (Engl); 2022 Aug; 135(15):1829-1836. PubMed ID: 35838554
[TBL] [Abstract] [Full Text] [Related]
4. Homeobox gene amplification and methylation in oral squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Esteves CD; Nascimento RB; Nobile JS; Severino P; de Cicco R; Toporcov TN; Tajara EH; Nunes FD
Arch Oral Biol; 2021 Sep; 129():105195. PubMed ID: 34126417
[TBL] [Abstract] [Full Text] [Related]
5. SLC1A5 Silencing Inhibits Esophageal cancer Growth via Cell Cycle Arrest and Apoptosis.
Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
[TBL] [Abstract] [Full Text] [Related]
6. Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014.
Karnov KKS; Grønhøj C; Jensen DH; Wessel I; Charabi BW; Specht L; Kjaer A; von Buchwald C
Acta Oncol; 2017 Sep; 56(9):1204-1209. PubMed ID: 28366106
[TBL] [Abstract] [Full Text] [Related]
7. Pediatric nasopharyngeal carcinoma: Experience from a tertiary cancer center in India.
Radhakrishnan V; Kumar P; Totadri S; Ganesan P; Selvaluxmy G; Ganesan T; Dhanushkodi M; Sagar T
Indian J Cancer; 2016; 53(3):377-380. PubMed ID: 28244463
[TBL] [Abstract] [Full Text] [Related]
8. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract] [Full Text] [Related]
9. A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
Cohen EE; Tortorici M; Kim S; Ingrosso A; Pithavala YK; Bycott P
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1261-70. PubMed ID: 25315258
[TBL] [Abstract] [Full Text] [Related]
10. POU2F1 activity regulates HOXD10 and hoxd11 promoting a proliferative and invasive phenotype in head and neck cancer.
Sharpe DJ; Orr KS; Moran M; White SJ; McQuaid S; Lappin TR; Thompson A; James JA
Oncotarget; 2014 Sep; 5(18):8803-15. PubMed ID: 25301728
[TBL] [Abstract] [Full Text] [Related]
11. Clinical character of pediatric head and neck rhabdomysarcomas: a 7-year retrospective study.
Zhang WL; Zhang Y; Huang DS; Guo F; Han T; Hong L; Hu HM; Zhi T
Asian Pac J Cancer Prev; 2013; 14(7):4089-93. PubMed ID: 23991958
[TBL] [Abstract] [Full Text] [Related]
12. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.
Chang H; Gao J; Xu BQ; Guo SP; Lu RB; Li G; Huang SM; Han F; Liu ZG; Tao YL; Tu ZW; Chen C; Li XH; Xia YF
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):639-46. PubMed ID: 23910226
[TBL] [Abstract] [Full Text] [Related]
13. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract] [Full Text] [Related]
14. Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma.
Rodini CO; Xavier FC; Paiva KB; De Souza Setúbal Destro MF; Moyses RA; Michaluarte P; Carvalho MB; Fukuyama EE; ; Tajara EH; Okamoto OK; Nunes FD
Int J Oncol; 2012 Apr; 40(4):1180-8. PubMed ID: 22227861
[TBL] [Abstract] [Full Text] [Related]
15. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection.
Haddadin KJ; Soutar DS; Oliver RJ; Webster MH; Robertson AG; MacDonald DG
Head Neck; 1999 Sep; 21(6):517-25. PubMed ID: 10449667
[TBL] [Abstract] [Full Text] [Related]
16. [Studies on the relationship between HPV and respiratory tract tumors. I. Correlation between HPV and laryngeal carcinoma].
Cui H; Yang X; He Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):109-15. PubMed ID: 7987936
[TBL] [Abstract] [Full Text] [Related]
17. Iridium-192 interstitial implant and external beam radiation therapy in the management of squamous cell carcinomas of the tonsil and soft palate.
Behar RA; Martin PJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):221-7. PubMed ID: 8270445
[TBL] [Abstract] [Full Text] [Related]
18. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract] [Full Text] [Related]
19. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract] [Full Text] [Related]
20. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
[TBL] [Abstract] [Full Text] [Related]
